Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | NNMT/PNMT/TEMT family protein | 0.5383 | 0.5 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.5383 | 0.5 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.5383 | 0.5 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
-Log KD50 (functional) | = 6.52 | Negative log antagonist concentration causing 50% displacement of [3H]-nifedipine from guinea pig ileal smooth muscle membrane. | ChEMBL. | 3560157 |
Bmax1 (binding) | = 100 % | Bmax1 from dihydropyridine receptor binding assay in guinea pig myocardial membranes | ChEMBL. | 2834556 |
IC50 (functional) | = 3050 nM | Compound was tested for ability to relax potassium-con-tracted rabbit aorta smooth muscle | ChEMBL. | 2834556 |
ID50 (functional) | = 3.2 M | Inhibition of muscarinic receptor mediated [Ca2+] dependent contraction of guinea pig ileal longitudinal smooth muscle. | ChEMBL. | 3560157 |
ID50 (functional) | = 32000000000 M | Inhibition of muscarinic receptor mediated [Ca2+] dependent contraction of guinea pig ileal longitudinal smooth muscle | ChEMBL. | 7057416 |
Kd1 (binding) | = 148 nM | Dissociation constant for inhibition of [3H]-nitrendipine binding to guinea pig myocardial membranes | ChEMBL. | 2834556 |
Log 1/EC50 (functional) | = 5.5 | Effective concentration required to produce mechanical response determined in muscle strips of guinea pig | ChEMBL. | 2846838 |
Log 1/IC50 (functional) | = 6.52 | Compound was tested for its antagonist activity against calcium channel | ChEMBL. | 2846838 |
Relative activity (functional) | = 0.16 | Calcium channel antagonistic activity relative to 2,6-Dimethyl-4-(2-nitro-phenyl)-1,4-dihydro-pyridine-3,5-dicarboxylic acid dimethyl ester(=100) | ChEMBL. | 7057416 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
4 literature references were collected for this gene.